SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
26-Apr-24 6:35 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 24-Apr-24 | Option Exercise | 2,893 | $39.35 | $113,840.00 | 7% 39.63K to 42.52K | |
13-Jun-23 10:00 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 09-Jun-23 | Grant | 1,142 | -- | -- | 3% 38.49K to 39.63K | |
18-May-23 5:18 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 16-May-23 | Sale | 4,444 | $77.20 | $343,081.00 | (10%) 42.93K to 38.49K | |
10-May-23 7:15 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 08-May-23 | Option Exercise | 6,408 | $18.82 | $120,599.00 | 15% 42.21K to 48.62K | |
10-May-23 7:15 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 08-May-23 | Option Sale | 6,408 | $76.56 | $490,628.00 | (13%) 48.62K to 42.21K | |
13-Jun-22 6:45 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 10-Jun-22 | Grant | 1,004 | -- | -- | 2% 41.21K to 42.21K | |
01-Mar-22 4:34 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 28-Feb-22 | Option Exercise | 7,335 | $12.53 | $91,907.50 | 21% 34.78K to 42.12K | |
01-Mar-22 4:34 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 28-Feb-22 | Option Sale | 908 | $102.62 | $93,179.00 | (2%) 42.12K to 41.21K | |
07-Jun-21 9:24 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 04-Jun-21 | Grant | 630 | -- | -- | 2% 34.15K to 34.78K | |
13-May-21 8:57 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 11-May-21 | Payment of Exercise | 391 | $128.56 | $50,267.00 | (1%) 34.54K to 34.15K | (< 1%) |
13-May-21 8:57 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 11-May-21 | Option Exercise | 4,835 | $10.12 | $48,930.20 | 16% 29.71K to 34.54K | |
23-Feb-21 5:18 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 22-Feb-21 | Option Exercise | 2,500 | $10.12 | $25,300.00 | 9% 27.21K to 29.71K | |
12-Jun-20 6:33 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 10-Jun-20 | Grant | 831 | -- | -- | 3% 26.38K to 27.21K | |
27-Aug-19 4:20 PM View: | Intec Pharma Ltd. (NTEC) | 23-Aug-19 | Market Purchase | 100,000 | $0.46 | $45,900.00 | 193% 51.76K to 151.76K | (70%) |
07-Jun-19 6:48 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 06-Jun-19 | Grant | 835 | -- | -- | 3% 25.54K to 26.38K | |
14-May-19 7:56 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 14-May-19 | Option Exercise | 2,500 | $17.88 | $44,700.00 | 10% 25.54K to 28.04K | |
14-May-19 7:56 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 14-May-19 | Market Option Sale | 2,500 | $112.92 | $282,300.00 | (9%) 28.04K to 25.54K | (15%) |
10-May-19 8:35 PM View: | Travere Therapeutics, Inc. (TVTX) | 08-May-19 | Grant | 2,000 | -- | -- | 7% 27.0K to 29.0K | |
02-Oct-18 6:24 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 01-Oct-18 | Market Sale (Planned) | 2,500 | $275.04 | $687,610.00 | (9%) 28.64K to 26.14K | 53% |
03-Jul-18 6:50 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 02-Jul-18 | Market Sale (Planned) | 2,500 | $207.48 | $518,699.00 | (8%) 31.14K to 28.64K | 37% |
21-Jun-18 4:41 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 19-Jun-18 | Grant | 493 | -- | -- | 2% 30.65K to 31.14K | |
07-Feb-19 10:00 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 14-May-18 | Gift | 600 | -- | -- | (2%) 30.65K to 30.05K | |
11-May-18 9:09 PM View: | Travere Therapeutics, Inc. (TVTX) | 09-May-18 | Grant | 2,500 | -- | -- | 10% 24.5K to 27.0K | |
03-Apr-18 4:50 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 02-Apr-18 | Market Sale (Planned) | 2,500 | $160.43 | $401,062.00 | (8%) 33.15K to 30.65K | 19% |
11-Jan-18 5:55 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 10-Jan-18 | Market Sale (Planned) | 2,500 | $145.00 | $362,500.00 | (7%) 35.65K to 33.15K | 10% |
17-Nov-17 5:14 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 16-Nov-17 | Market Sale | 5,000 | $141.71 | $708,550.00 | (12%) 40.65K to 35.65K | 8% |
26-May-17 8:16 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 25-May-17 | Grant | 666 | -- | -- | 2% 39.98K to 40.65K | |
18-May-17 6:20 PM View: | Travere Therapeutics, Inc. (TVTX) | 17-May-17 | Grant | 2,500 | -- | -- | 11% 22.0K to 24.5K | |
09-Sep-16 4:06 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 07-Sep-16 | Market Sale (Planned) | 1,000 | $115.00 | $115,000.00 | (2%) 40.98K to 39.98K | (13%) |
06-Sep-16 6:07 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 01-Sep-16 | Market Sale (Planned) | 1,666 | $105.40 | $175,597.00 | (4%) 40.98K to 39.32K | (24%) |
02-Aug-16 7:46 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 01-Aug-16 | Market Sale (Planned) | 1,000 | $137.57 | $137,569.00 | (2%) 41.98K to 40.98K | 5% |
05-Jul-16 7:56 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 01-Jul-16 | Market Sale (Planned) | 1,000 | $121.40 | $121,402.00 | (2%) 42.98K to 41.98K | (7%) |
03-Jun-16 4:41 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 01-Jun-16 | Market Sale (Planned) | 1,000 | $117.42 | $117,419.00 | (2%) 43.98K to 42.98K | (11%) |
25-May-16 7:16 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 23-May-16 | Grant | 622 | -- | -- | 1% 43.71K to 44.33K | |
03-Jun-16 4:41 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 20-May-16 | Gift | 350 | -- | -- | (< 1%) 43.71K to 43.36K | |
19-May-16 1:34 PM View: | Travere Therapeutics, Inc. (TVTX) | 18-May-16 | Grant | 2,000 | -- | -- | 10% 20.0K to 22.0K | |
03-May-16 5:34 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 02-May-16 | Market Sale (Planned) | 1,000 | $121.57 | $121,568.00 | (2%) 44.71K to 43.71K | (7%) |
07-Apr-16 5:30 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 06-Apr-16 | Market Sale (Planned) | 5,000 | $115.00 | $575,000.00 | (10%) 49.71K to 44.71K | (13%) |
22-Jan-16 7:24 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 20-Jan-16 | Option Exercise | 1,666 | $59.40 | $98,960.40 | 3% 49.71K to 51.38K | |
22-Jan-16 7:24 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 20-Jan-16 | Market Option Sale (Planned) | 1,666 | $94.94 | $158,173.00 | (3%) 51.38K to 49.71K | (37%) |
01-Jul-15 4:01 PM View: | QLT Inc. (NVLNF) | 29-Jun-15 | Option Exercise | 25,000 | $3.48 | $87,125.00 | 78% 32.0K to 57.0K | |
09-Jun-15 8:58 PM View: | QLT Inc. (NVLNF) | 07-Jun-15 | Option Exercise | 10,000 | -- | -- | 45% 22.0K to 32.0K | |
18-May-15 4:24 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 15-May-15 | Gift | 500 | -- | -- | (< 1%) 50.21K to 49.71K | |
27-Apr-15 7:54 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 24-Apr-15 | Grant | 925 | -- | -- | 2% 49.29K to 50.21K | |
03-Apr-15 8:12 PM View: | Travere Therapeutics, Inc. (TVTX) | 01-Apr-15 | Grant | 20,000 | -- | -- | 100% 0 to 20.0K | |
23-Dec-14 2:03 PM View: | QLT Inc. (NVLNF) | 22-Dec-14 | Market Purchase | 8,300 | $3.62 | $30,060.80 | 61% 13.7K to 22.0K | (49%) |
23-Dec-14 2:03 PM View: | QLT Inc. (NVLNF) | 19-Dec-14 | Market Purchase | 1,700 | $3.45 | $5,865.00 | 14% 12.0K to 13.7K | (47%) |
17-Dec-14 3:07 PM View: | QLT Inc. (NVLNF) | 15-Dec-14 | Option Exercise | 2,000 | -- | -- | 20% 10.0K to 12.0K | |
15-Oct-14 7:02 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 15-Oct-14 | Market Purchase | 2,000 | $45.68 | $91,360.00 | 4% 47.29K to 49.29K | 185% |
09-Oct-14 1:50 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 07-Oct-14 | Option Exercise | 2,500 | $8.58 | $21,450.00 | 6% 44.79K to 47.29K |